Abstract
Whether hepatocellular carcinoma (HCC) can be induced by viruses or not is a recent area of study in the field of molecular biomedicine and also a medical issue of worldwide concern. In Japan, cancer claims the life of 190,000 people a year and now ranks as the number one cause of death. Deaths from the disease have recently exceeded the figures for circulatory diseases, which kill more than 140,000 annually. We have overcome diseases caused by bacteria one after the other, with tuberculosis as a most recent example, and as a result during these past decades, our average life span has been extended significantly. In parallel with this extended longevity, cancer and circulatory diseases have begun to draw general attention today.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Amano S, Yamamoto H (1960) Infectious hepatitis and cirrhosis as its sequela in Japan. Annual Report of the Institute for Virus Research, Kyoto University 3: 185–334
Sheldon WH, James DF (1948) Cirrhosis following infectious hepatitis. A report of five cases, in two of which there were superimposed primary liver cell carcinoma. Arch Intern Med 81: 666–689
Walsche JW, Wolffe HH (1952) Primary carcinoma of the liver following viral hepatitis. Report of two cases. Lancet 2: 1007–1010
WHO report: Viral hepatitis. (1973) WHO Tech Rep Ser No. 512
Nishioka K, Hirayama T, Sekine T, Okochi K, Marumi M, Sung J-L, Liu C-H, Lin T-M (1973) Australia antigen and HCC. Gann Monograph Cancer Research 14: 167–175
Nishioka K, Levin A, Simons MJ (1975) Hepatitis B antigen, antigen subtypes, and hepatitis B antibody in normal subjects and patients with liver disease. Result of collaborative study. Bull. WHO 52: 293–300
Nishioka K (1978) Hepatocellular carcinoma and hepatitis B virus. In: Oda T (ed) Hepatitis Virus. Tokyo University Press, Tokyo, pp 247–255
Obayashi A, Okochi K, Marumi M (1972) Familial clustering of asymptomatic carriers of Australia antigen and patients with chronic liver disease or primary liver cancer. Gastroenterology 62: 618–625
Shikata T, Uzawa T, Yoshihara N, Akatsuka T, Yamazaki S (1974) Staining methods for Australia antigen in paraffin section. Jap J Exp Med 44: 25–36
Assaad F (1985) Global overview of hepatitis B vaccine, WHO-WPR, 3rd Task Force Meeting on Hepatitis B
The Liver Cancer Study Group of Japan (1984) Primary liver cancer in Japan. Cancer 54: 1747–1755
Nishioka K, Watanabe J, Furuta S, Tanaka E, Iino S, Suzuki H, Tsuji T, Yano M, Kuo G, Choo Q-L, Houghton M, Oda T (1991) A high prevalence of antibody to the hepatitis C virus in patients with HCC in Japan. Cancer 67: 429–433
Kim C, Koike K, Saito I, Miyamura T, Jay G Nature 351:317–320, 1991 HB-X gene of hepatitis B virus induces hepatic carcinoma in transgenic mouse. Nature
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag Tokyo
About this chapter
Cite this chapter
Oda, T. (1992). Historical overview of research into the etiology of hepatocellular carcinoma. In: Tobe, T., et al. Primary Liver Cancer in Japan. Springer, Tokyo. https://doi.org/10.1007/978-4-431-68177-9_6
Download citation
DOI: https://doi.org/10.1007/978-4-431-68177-9_6
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-68179-3
Online ISBN: 978-4-431-68177-9
eBook Packages: Springer Book Archive